Marie Claire gets the nod from its audience. When you purchase through links on our site, we may earn a commission on some of the items you choose to purchase.
Yep, you read that right.
In Covid news today, the UK has become the first country in the world to approve a new Covid vaccine specifically designed to target the Omicron strain of the virus.
The ministers gave the green light to the jab, which is called “Spikevax.”
Moderna – the company that has developed the new vaccine – shares its hopes that around 13 million doses can be given in time for the autumn when ministers plan to launch the next booster campaign.
That said, they have warned the public not to get set on a specific type, as you will be injected with whatever jab they have available for the day. After all, they were all developed and approved with the same goal in mind – to protect you from the virus.
Some fun facts for you: The new vaccine is bivalent, which essentially means that it is multi-faceted and can do two jobs at the same time. It targets both the original Covid-19 virus but also the many new strains and mutations of it.
Speaking to the BBC, a representative from the UK’s Medicines and Healthcare products Regulatory Agency, Dr June Raine, stressed that the drug has indeed been reviewed, tested on 473 people so far, and would not have been approved by UK regulators without rigorous testing.
“What this bivalent vaccine gives us is a sharpened tool in our arsenal to protect us against this disease as the virus continues to evolve,” she said.
If you’re at all concerned about the vaccine and your fertility or how long the vaccine’s side effects last, we’ve asked some of the top experts in the business to explain why you don’t have to be. Haven’t had Covid yet and wondering why? Our guide can help you.
When tested, the results showed that Spikevax is effective in offering immune protection against the newer variants – more so than other vaccines.
Wondering if you might be eligible for a Spikevax vaccine? Good question – and one we don’t yet have an answer to. The relevant regulatory boards will determine who is most eligible for the vaccines and distribute them accordingly.
Whatever vaccine you get – it’s here to protect ourselves and others.